ENvue Medical (FEED) Non-Current Deferred Tax Liability (2024 - 2025)
ENvue Medical's (FEED) quarterly Non-Current Deferred Tax Liability came in at $885000.0 in Q4 2025, up 17600.0% year-over-year from N/an in Q4 2024, and up 17600.0% quarter-over-quarter from $5000.0 in Q4 2024.
Powered by 
Analysis
ENvue Medical (FEED) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends
ENvue Medical (FEED) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $885000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 17600.0% year-over-year to $885000.0 in Q4 2025; TTM through Dec 2025 was $885000.0, a 17600.0% increase from a year earlier, with the FY2025 full-year figure at $885000.0, up 17600.0% from the prior year.
- Non-Current Deferred Tax Liability was $885000.0 for Q4 2025 at ENvue Medical, up from $5000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $885000.0 in Q4 2025 and troughed at $5000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 |